Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir

NCT02092116 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV I Infection

Interventions

DRUG: Romidepsin
BIOLOGICAL: Vacc-4x
BIOLOGICAL: rhuGM-CSF

Sponsor

Bionor Immuno AS

Collaborators

[object Object]